Inhibrx Biosciences, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
INBX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA

Insiders trading volume in the past year

Inhibrx Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mark Lappe Chief Executive Officer, Director $15.9M Sep 12, 2024
Jon Faiz Kayyem Director $15M May 28, 2025
Brendan P. Eckelman Chief Scientific Officer $6.13M May 29, 2024
Viking Global Investors Lp 10%+ Owner $3.32M -$11.3M -77.3% Oct 7, 2025
Douglas Forsyth Director $3.16M May 28, 2025
Kristiina MD Vuori Director $307K May 28, 2025
Kimberly Manhard Director $140K May 28, 2025
Kelly Deck Chief Financial Officer Apr 1, 2025
David Matly President Apr 1, 2025
Inhibrx, Inc. 10%+ Owner May 29, 2024

Recent Insider Transactions by Companies or Individuals for Inhibrx Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.